ChromoGenics receives the first commercial reference order in Denmark of SEK 250 thousand

Report this content

ChromoGenics AB (publ) has signed an agreement with Byggeselskab Mogens de Linde, a leading property development company in Denmark, to deliver ConverLight dynamic glass to a conference room in an office property on Dalgas Avenue in central Aarhus.

The order is an extension project to which energy-efficient ConverLight dynamic glass has been chosen in front of traditional solution for a better indoor climate. Delivery is scheduled for the fourth quarter of 2018.

"We are proud that Byggeselskab Mogens de Linde has chosen ConverLight dynamic glass for its real estate in central Aarhus, Denmark. The order is important to be used as reference project for future sales projects in Denmark. ConverLight controls heat and light transmission in to buildings, which improves indoor comfort. The order demonstrates the need for modern, energy efficient and maintenance-free solar control solutions, with maintained views that also contribute to Green building certifications," says Jerker Lundgren, CEO of ChromoGenics.

Jerker Lundgren, CEO 
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 





Documents & Links